VBS — Vectus Biosystems Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- AU$3.94m
- AU$3.89m
- AU$0.02m
Annual cashflow statement for Vectus Biosystems, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.543 | 0 | 2.2 | 1.59 | 0.996 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.26 | -4.44 | -2.35 | -2.03 | -0.83 |
| Capital Expenditures | — | -0.021 | -0.017 | -0.068 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.101 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.021 | -0.017 | -0.068 | 0.101 |
| Financing Cash Flow Items | -0.113 | 0 | -0.063 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.35 | -0.035 | 4.04 | -0.041 | 0.171 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.09 | -4.5 | 1.67 | -2.14 | -0.558 |